Effects of 6-hydroxydopamine on the nature of proteins undergoing axoplasmic transport in nigro-neostriatal neurons.
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D002421:Caudate Nucleus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002848:Chromatography, DEAE-Cellulose; D003342:Corpus Striatum / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D011699:Putamen / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D014461:Ultracentrifugation
D006892:Hydroxydopamines; D009419:Nerve Tissue Proteins; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase; D007930:Leucine